Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 84: 791-797, 1998;
8750-7587/98 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dishart, M. K.
Right arrow Articles by Gayowski, T. J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dishart, M. K.
Right arrow Articles by Gayowski, T. J. P.

Vol. 84, Issue 3, 791-797, March 1998

Mitochondrial redox state as a potential detector of liver dysoxia in vivo

Michael K. Dishart, Robert Schlichtig, Tor Inge Tønnessen, Ranna A. Rozenfeld, Elena Simplaceanu, Donald Williams, and Timothy J. P. Gayowski

Department of Research and Development, Veterans Affairs Medical Center, Pittsburgh 15240; and Departments of Anesthesiology and Critical Care Medicine, Internal Medicine, and Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania 15261

    ABSTRACT
Top
Abstract
Introduction
Methods
Results
Discussion
References

Dysoxia can be defined as ATP flux decreasing in proportion to O2 availability with preserved ATP demand. Hepatic venous beta -hydroxybutyrate-to-acetoacetate ratio (beta -OHB/AcAc) estimates liver mitochondrial NADH/NAD and may detect the onset of dysoxia. During partial dysoxia (as opposed to anoxia), however, flow may be adequate in some liver regions, diluting effluent from dysoxic regions, thereby rendering venous beta -OHB/AcAc unreliable. To address this concern, we estimated tissue ATP while gradually reducing liver blood flow of swine to zero in a nuclear magnetic resonance spectrometer. ATP flux decreasing with O2 availability was taken as O2 uptake (VO2) decreasing in proportion to O2 delivery (QO2); and preserved ATP demand was taken as increasing Pi/ATP. VO2, tissue Pi/ATP, and venous beta -OHB/AcAc were plotted against QO2 to identify critical inflection points. Tissue dysoxia required mean QO2 for the group to be critical for both VO2 and for Pi/ATP. Critical QO2 values for VO2 and Pi/ATP of 4.07 ± 1.07 and 2.39 ± 1.18 (SE) ml · 100 g-1 · min-1, respectively, were not statistically significantly different but not clearly the same, suggesting the possibility that dysoxia might have commenced after VO2 began decreasing, i.e., that there could have been "O2 conformity." Critical QO2 for venous beta -OHB/AcAc was 2.44 ± 0.46 ml · 100 g-1 · min-1 (P = NS), nearly the same as that for Pi/ATP, supporting venous beta -OHB/AcAc as a detector of dysoxia. All issues considered, tissue mitochondrial redox state seems to be an appropriate detector of dysoxia in liver.

adenosine 5'-triphosphate; nuclear magnetic resonance; oxygen delivery; ischemia; pig

    INTRODUCTION
Top
Abstract
Introduction
Methods
Results
Discussion
References

DETECTION OF TISSUE DYSOXIA, i.e., O2 supply that is inadequate to support O2 demand (5, 24), may facilitate understanding and management of critically ill patients. Current clinical management of O2 transport to tissue in critically ill patients typically involves measurement (6) and improvement (9, 11) of cardiac output. However, these practices are currently intensely debated (21). Cardiac output is certainly essential for rapid diagnosis of hemodynamic instability but is a whole body parameter. Use of it to guide therapy requires the clinician to assume that it is evenly distributed to all organs under all conditions, including septic vasodilation or constriction, infusion of pressor agents, and positive-pressure mechanical ventilation. Hence, an "adequate" cardiac output does not necessarily signify adequate O2 supply to all organs. A potential improvement on clinical trials of cardiac output measurement and manipulation might be to look for dysoxia directly in suspect tissues such as the splanchnic viscera. However, such methods do not currently exist for these organs.

In time, liver dysoxia causes leakage of intracellular hepatic enzymes that can be measured in plasma. However, nondysoxic conditions such as inflammation after autologous liver transplantation produce the same abnormalities. Lactate accumulates during dysoxia but also during seemingly nondysoxic conditions such as exercise (10) and septic inhibition of pyruvate dehydrogenase (7, 28). Tissue PO2 and related parameters (12) are frequently measured but by themselves do not distinguish between adapted hypoxia and dysoxia (5). Bulk O2 delivery (QO2), the product of blood O2 and flow, can be progressively reduced until organ O2 uptake (VO2) begins to decrease, so as to identify a critical QO2 that no longer supports VO2 (O2 supply dependence) (2, 20). However, application of this biphasic VO2-QO2 model to liver is not practical in patients.

Part of the problem has been that, until recently, criteria for recognizing dysoxia have not been carefully defined. Connett et al. (5) proposed that tissue dysoxia is probable if changes in intracellular O2 availability are accompanied by parallel changes in ATP flux at constant ATP demand. We (24) evaluated mitochondrial redox state as a detector of dysoxia in liver from the perspective of the biphasic VO2-QO2 model by reducing liver blood flow progressively to zero. Using whole organ QO2 as our measure of intracellular O2 availability, VO2 as our estimate of ATP flux, and hepatic mitochondrial redox state as our measure of ATP demand (32), we observed parallel decreases in ATP flux below a critical QO2, with ATP demand increasing relative to supply approximately simultaneously. These findings suggested that whole liver O2 supply dependence represented dysoxia and that mitochondrial redox state might be an appropriate method for detecting it.

The measure of mitochondrial redox state that we had used was hepatic venous beta -hydroxybutyrate-to-acetoacetate concentration ratio (beta -OHB/AcAc). beta -OHB/AcAc equilibrates with hepatic mitochondrial NADH/NAD because the enzyme, beta -hydroxybutyrate dehydrogenase, resides in mitochondrial cristae (15). However, we did not sample beta -OHB/AcAc in tissue. Several investigations (19, 23, 29) suggest a sharp demarcation between adequately perfused and completely unperfused tissue. Hence, it was not clear why beta -OHB/AcAc in liver effluent should reliably identify the onset of dysoxia. For example, CO2 produced anaerobically in ischemic dysoxic intestine seems to detect intestinal dysoxia (19, 23). However, this CO2 is trapped in tissue, such that CO2 must be measured directly in tissue, as opposed to portal venous effluent.

To begin further addressing the sensitivity for dysoxia of venous beta -OHB/AcAc specifically, and hepatic mitochondrial redox state in general, we measured Pi and ATP by 31P-nuclear magnetic resonance (NMR) in livers of six supine swine. Tissue dysoxia was defined as ATP flux (estimated as organ VO2), which decreased with cellular O2 availability (estimated as organ QO2) accompanied by an increase in tissue ATP demand relative to supply (estimated as Pi/ATP). The concurrance of these phenomena (dysoxia) was compared with the increase in hepatic venous beta -OHB/AcAc relative to liver QO2.

    METHODS
Top
Abstract
Introduction
Methods
Results
Discussion
References

Surgical preparation. In a protocol approved by the Institutional Animal Care and Use Committee, six juvenile swine weighing 22.6 ± 0.6 kg each were fasted for 12 h with unlimited access to water, sedated with intramuscular ketamine hydrochloride (10 mg/kg), and anesthetized with intravenous pentobarbital sodium (20 mg/kg). A tracheostomy was performed, and mechanical ventilation was initiated through a 7-mm cuffed tracheal tube. Ventilator rate, tidal volume, and inspired O2 concentration were adjusted to keep arterial PO2 near 150 Torr and arterial PCO2 near 40 Torr. Through extension of the tracheostomy incision, the right internal jugular vein was cannulated, and pentobarbital infusion was started at 3-5 mg · kg-1 · h-1. The right carotid artery was cannulated, and mean arterial pressure was continuously monitored. Through an incision in the left flank, the origins of the superior mesenteric artery and the celiac artery, the main conduits of cardiac output to liver, were dissected free through a retroperitoneal approach, and elastic snares were placed loosely around these vessels. Through a low midline incision, the inferior mesenteric artery was ligated to prevent uncontrolled flow to liver via this source. This incision was closed in two layers. Through a high midline incision, the liver was isolated from potential diaphragmatic collateral flow as completely as possible, and the diaphragm was separated from the vena cava. The bile duct was divided, and both ends were ligated to expose the common hepatic artery, and a drainage tube was placed in the gallbladder, to prevent increased pressure in the biliary system. The common hepatic artery was exposed by blunt dissection, and pancreatic, gastric, and duodenal branches were ligated. The portal vein was exposed, and a 7-Fr triple-lumen catheter was inserted into it through a lymph node to the level of the porta hepatis by the Seldinger technique (25). A 6-mm ultrasonic flow probe (Transonics Systems no. 6RB) was placed around the hepatic artery, and a 10-mm flow probe (no. 10SB) around the portal vein. The left hepatic vein was identified by palpation, and a 16-gauge catheter was inserted into it through the liver capsule by the the Seldinger technique to a distance of ~5 cm from the vena cava. A temperature probe was placed on the surface of the liver. The high midline incision was then partially closed, leaving an opening large enough for placement of a 35-mm NMR coil. The remaining exposed liver surface was covered with transparent plastic wrap to prevent tissue dehydration, and the animal was transported to the NMR suite. All monitoring and life-supporting devices were equipped with extra lengths of cable or tubing as appropriate. Ventilator tubing of a larger than usual diameter proved necessary to prevent unwanted positive end-expiratory pressure and consequent decreased venous return.

31P-NMR spectroscopy. A single-turn NMR surface coil, 35 mm in outer diameter, was placed on the ventral liver surface, and its stability with ventilatory hepatic movement was verified. The NMR coil was single tuned to 81 MHz, the resonance frequency of 31P. An external standard consisting of 0.25 mM methylenediphosphonic acid (MDPA) in 2H2O was affixed to the coil. The entire preparation was then placed inside a 40-cm horizontal-bore 4.7 T superconducting magnet, with a Bruker BIOSPEC II spectrometer operating at 81 MHz. The homogeneity of the magnetic field was optimized by shimming on the water proton signal. Typical line widths of 60-90 Hz were obtained. The animal was supine inside a cradle fashioned from large-diameter polyvinyl chloride pipe, with the elastic snares around celiac and superior mesenteric arteries secured to a pair of plastic screws, which were attached to the cradle. One operator adjusted these screws, directed by another who monitored the flow meter, thereby permitting maintainence of reasonably constant target blood flow values.

To acquire 31P-NMR spectra, 60 scans with an optimum radio-frequency pulse of 80 µs, spectral width of 6 KHz, and size of 1,024 points were averaged for a period of ~4.5 min/spectrum. An interpulse delay of >4 s was necessary to achieve full relaxation of all phosphorous peaks. The triggering pulse for each acquisition was synchronized with ventilation, by using a gating device activated by the ventilator at the same point in each respiratory cycle.

Measurements and calculations. Mean arterial pressure was monitored with a pressure transducer (Hewlett Packard 78304A). Blood hemoglobin concentration and percent oxyhemoglobin were measured with an Instrumentation Laboratory 482 CO-oximeter. Plasma pH, PCO2, and PO2 were measured with a Radiometer ABL-620 blood-gas analyzer. Hepatic arterial and portal venous blood flows were measured with a Transonics T-201 two-channel meter. Accuracy of the meter had previously been ascertained by placing the flow probes around latex surgical drains submersed in saline without air bubbles, permitting saline to flow by gravity through the drains at various rates, and comparing timed collection of saline drainage to Doppler flow averaged over the same time period by computer.

Hepatic venous AcAc concentration was measured by using the enzymatic technique of Mellanby and Williamson (16). Hepatic venous beta -OHB concentration was measured by using Brashear's modification of the technique of Williamson and Mellanby (1). Hepatic QO2 and hepatic VO2 were calculated by standard methods as previously described (24), with the exception that here hepatic arterial flow was surgically isolated.

31P-NMR spectral peak areas for ATP, Pi, and MDPA were determined by integration with the use of the Bruker software package. Before integration, baseline correction with the polynomial curve-fitting routine from the same software package was applied for each spectrum. All peaks were normalized to the MDPA peak to reduce variability among measurements. Hepatic Pi/ATP was calculated as Pi peak area divided by beta -ATP peak area. Pi/ATP, as opposed to relative ATP concentration, corrected for the apparent liver contraction that occurred during flow stagnation.

Experimental protocol. At t = 0, hepatic arterial and portal venous blood flows were collected for 30 s and averaged by computer. Immediately afterward, arterial, portal venous, and hepatic venous blood samples were taken, followed by two 31P-NMR spectra, followed immediately by a second set of blood samples. After each data collection, blood flows to the celiac and the superior mesenteric arteries were immediately reduced by 10% of baseline flow value. This process was repeated 10 times, allowing 20 min between data collections. 31P-NMR data acquisition required ~10 min, so that each period of constant flow lasted 30 min. The animal was then killed with a bolus of intravenous pentobarbital sodium (10 mg/kg) followed by concentrated potassium chloride. At necropsy, correct placement of the hepatic venous cannula was confirmed, and the livers (751 ± 39 g) were weighed.

Data analysis. Dysoxia was defined as ATP flux, which decreases in proportion to O2 availability with preserved ATP demand (5). We used whole organ VO2 as our measure of ATP flux, since the two are usually tightly coupled. To check this assumption, we retrospectively plotted relative ATP against VO2, reasoning that a positive correlation between these variables would indicate that VO2 is a reasonable measure of ATP flux. We used QO2 as our measure of O2 availability. Most evidence indicates that, for practical purposes, tissue O2 availability depends on bulk transport or convection of O2 (i.e., QO2), as opposed to venous PO2, or diffusion, at rest (22). Hence, ATP flux decreasing in proportion to O2 availability was taken as O2 supply dependence (2, 20). We also plotted VO2 as a function of hepatic venous PO2, to be certain that ATP flux also decreased in proportion to this alternative measure of tissue O2 availability. We used tissue Pi/ATP as our measure of preserved ATP demand, since Pi/ATP, like mitochondrial redox state, increases as cellular PO2 approaches dysoxic levels (32).

O2 supply dependence or ATP flux decreasing in proportion to O2 availability was defined for each individual animal by plotting VO2 against QO2 and obtaining critical inflection points by the standard method of Samsel and Schumacker (20). Onset of increasing ATP demand relative to supply (32) was defined in the same manner for each animal, by plotting Pi/ATP against QO2. To determine whether the onset of these two criteria required for dysoxia was different, we compared these two critical QO2 values by two-tailed paired difference t-test, taking significance as P < 0.05. To determine whether hepatic venous beta -OHB/AcAc increased at a QO2 value different from that which defined dysoxia, we compared critical inflection values for VO2 and beta -OHB/AcAc (computed in the same manner) and Pi/ATP by two-tailed paired difference t-test, with significance taken as P < 0.05. In one instance (beta -OHB/AcAc vs. QO2 relation of subject 6), the least and second-least sum of squares regression lines intersected outside the range of QO2 studied. In this instance, the third-least sum of squares pair of regression lines was used to calculate critical QO2. Statistical significance would support the hypothesis that critical values were different, although statistical insignificance would not necessarily indicate that they were the same. This was a limitation of our analysis.

A more rigorous method might be to define dysoxia as the lowest critical QO2 value satisfying both decreasing VO2 and increasing Pi/ATP for each individual animal and to compare this lowest common QO2 value with that for hepatic venous beta -OHB/AcAc. However, data collection proved more difficult in an NMR scanner than during our usual laboratory conditions, causing increased data scatter, such that this alternative method would have biased the data toward lower QO2 values for dysoxia.

    RESULTS
Top
Abstract
Introduction
Methods
Results
Discussion
References

Figure 1 shows average values ± SE for directly measured variables. Mean arterial pressure remained reasonably constant as flow to the splanchnic viscera was progressively decreased. Flow in the superior mesenteric and hepatic arteries decreased linearly in proportion to time intervals. Divergence of venous beta -OHB from venous AcAc occurred approximately simultaneously with divergence of tissue Pi from tissue ATP. Figure 2 shows 31P-NMR spectra data for one animal. Unlike skeletal muscle, liver contains no creatine phosphate (13). Figure 3 shows pooled data for the group of six animals. Figure 3A shows whole liver VO2 (or ATP flux) as a function of hepatic venous PO2. Venous PO2 values associated with the lowest VO2 values were widely variable, presumably reflecting aspiration of some inferior vena caval blood. VO2 was relatively constant at venous PO2 >20 Torr, below which this estimate of ATP flux decreased with decreasing PO2. Figure 3B shows VO2 and relative ATP as a function of whole liver bulk QO2. ATP was relatively constant during O2 supply independence, decreasing at the onset of O2 supply dependence. The assumption that VO2 was a reasonable reflection of ATP flux in our preparations was supported by the linear relation (r2 = 0.59) between ATP and whole organ VO2 (Fig. 3C). Figure 3D shows the relation between venous beta -OHB/AcAc and ventral tissue Pi/ATP as a function of QO2. These pooled venous beta -OHB/AcAc and ventral parenchymal Pi/ATP vs. QO2 relations were superimposable, with inflections commencing at the approximate onset of O2 supply dependence. These pooled data support ATP flux (VO2) decreasing in proportion to tissue O2 availability (venous PO2 and whole organ QO2), with O2 demand increasing relative to supply approximately simultaneously in tissue (Pi/ATP), satisfying the three criteria for recognizing dysoxia (5). The strikingly similar behavior of venous beta -OHB/AcAc and tissue Pi/ATP as QO2 and VO2 decreased supported our hypothesis that venous beta -OHB/AcAc in particular, and mitochondrial redox state in general, detect dysoxia in liver.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 1.   Values are means ± SE of directly measured variables as a function of time. square , Arterial values; open circle , portal venous values; bullet , hepatic venous values. Brackets indicate concentration. MAP, mean arterial pressure; pHp, plasma pH; La-p, plasma lactate; AcAc, acetoacetate; beta -OHB, beta -hydroxybutyrate; MDPA, methylenediphosphonic acid.


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 2.   Raw 31P-nuclear magnetic resonance spectral data. First of 2 spectra acquired at each data-collection time is shown. PME, phosphomonoester; PDE, phosphodiester.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 3.   Pooled data from 6 animals. A: whole organ O2 uptake (VO2) as a function of hepatic vein PO2. B: ventral parenchymal [ATP] and whole organ VO2 as a function of O2 delivery (QO2). C: correlation between relative ATP and VO2. D: hepatic vein beta -OHB/AcAc and surface Pi/ATP as a function of whole organ QO2.

Figure 4 shows venous beta -OHB/AcAc (left), ventral parenchymal Pi/ATP (middle), and VO2 (right) as a function of whole organ QO2 for each of the six animals. In several instances, critical values given by the dual-line regression program were not where intuition might have placed them. However, dual-line regression is the only available observer-unbiased method for detecting inflection points (20). Critical QO2 was 2.44 ± 0.46 (SE) ml · 100 g-1 · min-1 for venous beta -OHB/AcAc; 2.39 ± 1.18 ml · 100 g-1 · min-1 for ventral parenchymal Pi/ATP; and 4.07 ± 1.07 ml · 100 g-1 · min-1 for VO2 (P = not significant), indicating that critical values were not different, although not necessarily that they were the same.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 4.   Hepatic vein beta -OHB/AcAc (left), surface Pi/ATP (middle), and whole organ VO2 (right) as a function of whole organ QO2. Dual-regression lines are shown on each plot.

    DISCUSSION
Top
Abstract
Introduction
Methods
Results
Discussion
References

Measurement of mitochondrial redox state in intact liver was introduced by Chance and colleagues (4) in the 1960s. Their subsequent use of dual O2 indicators later showed that tissue with PO2 approaching the dysoxic range was practically nonexistant in working rat heart (3) and in isolated perfused liver (27). These findings were important because mitochondria of isolated cells (stirred at homogeneous PO2) become ~50% reduced as O2 availability approaches inadequate (PO2 decreasing from ~5-15 Torr) (32). If PO2 of all cells in an intact organ were in the range of 5-15 Torr as the organ approached the dysoxic threshold, then mitochondrial reduction would be nonspecific for dysoxia. Hence, the dual O2-indicator technique supported the idea that hepatocytes residing together in a dysoxic organ ought to be segregated into a group that has sufficient O2 to saturate mitochondrial cytochromes and into another one that has so little O2 as to fully reduce mitochondrial cytochromes, with a small or nonexistent "border zone" of hepatocytes with intermediate O2. Such a segregation would permit partial (mean) mitochondrial reduction in whole organ to indicate that some parts of it are dysoxic.

Our previous investigation of venous beta -OHB/AcAc (24) supported hepatic mitochondrial redox state as a detector of liver dysoxia in situ, during the natural condition of progressive hemorrhagic ischemia. However, we had used venous beta -OHB/AcAc both as our measure of ATP demand and as our potential detector of dysoxia. Venous beta -OHB/AcAc is an indirect measure of tissue mitochondrial reduction and subject to potential dilution by blood flow from adequately perfused tissue. Here we defined dysoxia independently and compared the behavior of venous beta -OHB/AcAc to it. Convergence of all three phenomena: decreasing O2 availability (QO2), decreasing ATP flux (VO2), and preserved ATP demand (increasing Pi/ATP) demonstrated dysoxia. The virtual superimposibility of tissue Pi/ATP and vein beta -OHB/AcAc as ATP flux decreased in parallel with O2 availability (Fig. 3D) suggests, contrary to some views (5), that mean mitochondrial reduction in general, and venous beta -OHB/AcAc specifically, are potentially viable methods for detecting dysoxia in liver.

Flow in dysoxic regions. In isolated perfused heart (29) and in intestine in situ (19, 23), it appears that the dysoxic group of cells has not only no O2 but also very little blood flow, the remainder being adequately perfused. Metzger and Schywalsky (17, 26) provided data for intact dysoxic liver showing that perfused sinusoids are surrounded by unperfused sinusoids, suggesting a similar segregation of adequately perfused and completely unperfused segments in liver. However, both this and our previous (24) investigation indicate that sufficient dysoxic liver is perfused to permit detection of dysoxia by venous effluent beta -OHB/AcAc. The fraction of perfused dysoxic liver appears to increase as QO2 approaches zero.

Limitations of our findings. Scatter of data obtained from within an NMR scanner, particularly for VO2 (Fig. 4), produced variable critical inflection points, some not where intuition might have placed them. This limitation precluded defining dysoxia for each individual animal as a single QO2 value satisfying both O2 supply dependence (ATP flux decreasing with O2 availability) and increasing ATP demand. Hence, we cannot conclude that mitochondrial reduction identified the onset of dysoxia precisely. Both venous beta -OHB/AcAc and tissue Pi/ATP increased at a somewhat lower <A><AC>Q</AC><AC>˙</AC></A><SC>o</SC><SUB>2</SUB> value (~2.4 ml · 100 g-1 · min-1) than that at which VO2 increased (~4 ml · 100 g-1 · min-1). This discrepancy, although not statistically significant, could be interpreted to mean that hepatocytes down-regulated ATP demand (and, therefore, VO2) to adapt for decreased ATP supply, i.e., "O2 conformity," early in the progression of organ dysoxia.

Another limitation of our findings relates to the fact that we measured Pi/ATP only in ventral liver tissue, to a depth of ~1 cm. It is possible that some portions of liver were dysoxic while tissue monitored by the NMR probe was still adequately perfused, in which event venous beta -OHB/AcAc might have been insensitive for the onset of dysoxia. However, we measured Pi/ATP in an area of liver that we considered to be most vulnerable to dysoxia. This portion of liver was the greatest distance from inflowing portal venous and hepatic arterial blood supply, where resistance to blood flow might have been greatest. In addition, the hydrostatic pressure difference between aorta and monitored tissue in these supine animals, ~15-20 cmH2O (19), was maximum and presumably a substantive fraction of mean pressure distal to our vascular snares. In this regard, Lautt et al. (14) observed a tendency for both portal venous and hepatic arterial blood flow to distribute less to ventral than to dorsal liver in supine dogs and cats at normal flow values. This tendency might be more pronounced at pressures associated with critical flow values.

We could have avoided our problem of data scatter near critical had we employed hemodilution or anoxia. Flow would then have been greater at critical liver QO2, permitting better separation of potential differences in critical values. However, flow distribution during such high-flow dysoxic conditions might then be different than that occurring during ischemic dysoxia, predisposing to more homogeneous flow distribution near critical and favoring our idea that tissue redox state is sensitive for dysoxia. Both profound hypoxia and anemia are generally unusual, or at least short lived, in hospitalized patients, who are our concern. More importantly, the preparations studied earlier by Sies et al. (27) employing isolated perfused livers, i.e., high-flow dysoxia, had produced results similar to those reported here.

Clinical implications. An ideal clinical dysoxia-detection method would be sensitive, specific, safe, and practical at the bedside. Considerable evidence supports arterial AcAc/beta -OHB as a clinical tool, particularly for patients undergoing liver surgery (18). However, the enzyme, beta -hydroxybutyrate dehydrogenase, is contained in tissues in addition to liver (15). Therefore, we are not certain that beta -OHB/AcAc obtained from artery or from a vein other than the hepatic is specific for liver dysoxia in unstable patients, who have the potential for critical perfusion deficits in multiple organs. Hepatic vein catheters have been safely employed in some clinical investigations (8, 12) and might be used to assay beta -OHB/AcAc for investigative purposes, although probably not routinely to detect liver dysoxia in patients. The "critical" value for hepatic vein beta -OHB/AcAc seems to be near 1.0, although "critical" was defined by our dual-line regression program in one animal as 5.0 (Fig. 4). Hence, use of arterial or venous beta -OHB/AcAc as a potential clinical detector of liver dysoxia requires additional investigation. Alternatively, available noninvasive monitors of tissue mitochondrial redox state (30) could be further developed for clinical use, proving more practical than blood beta -OHB/AcAc in clinical management.

    ACKNOWLEDGEMENTS

We thank Tracy Ann Gavidia for providing technical and surgical assistance.

    FOOTNOTES

This work was supported by the Department of Veterans Affairs and by a Shertz fellowship of Dept. of Anesthesiology and Critical Care Medicine, University of Pittsburgh, Peter M. Winter, Chairman (to M. K. Dishart).

Address for reprint requests: R. Schlichtig, 45 Longuevue Dr., Pittsburgh, PA 15228.

Received 15 August 1996; accepted in final form 7 November 1997.

    REFERENCES
Top
Abstract
Introduction
Methods
Results
Discussion
References

1.   Brashear, A., and G. A. Cook. A spectrophotometric, enzymatic assay for D-3 hydroxybutyrate that is not dependent on hydrazine. Anal. Biochem. 131: 478-482, 1983[Medline].

2.   Cain, S. M. Peripheral oxygen uptake and delivery in health and disease. Clin. Chest Med. 4: 139-148, 1983[Medline].

3.  Chance, B. Discussion. Circ. Res. 38, Suppl. I: 69-74, 1976.

4.   Chance, B., B. Schoener, K. Krejct, W. Rüssman, W. Wesemann, H. Schnitger, and T. Bücher. Kinetics of fluorescence and metabolite changes in rat liver during a cycle of ischemia. Biochem. Zeit. 341: 325-333, 1965.

5.   Connett, R. J., C. R. Honig, T. E. J. Gayeski, and G. A. Brooks. Defining hypoxia: a systems review of VO2, glycolysis, energetics, and intracellular PO2. J. Appl. Physiol. 68: 833-842, 1990[Abstract/Free Full Text].

6.   Connors, A. F., T. Speroff, N. V. Dawson, C. Thomas, F. E. Harrell, D. Wagner, N. Desbiens, L. Goldman, A. W. Wu, R. M. Califf, W. J. Fulkerson, H. Vidaillet, S. Broste, P. Bellamy, J. Lynn, and W. A. Knaus. The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 276: 889-897, 1996[Abstract/Free Full Text].

7.   Curtis, S. E., and S. M. Cain. Regional and systemic oxygen delivery/uptake relations and lactate flux in hyperdynamic, endotoxin-treated dogs. Am. Rev. Respir. Dis. 145: 348-354, 1992[Medline].

8.   Dahn, M. S., P. Lange, R. F. Wilson, L. A. Jacobs, and R. A. Mitchell. Hepatic blood flow and splanchnic oxygen consumption measurements in clinical sepsis. Surgery 107: 295-301, 1990[Medline].

9.   Gattinoni, L., L. Brazzi, P. Pelosi, R. Latini, G. Tognoni, A. Pesenti, and R. Fumagalli. A trial of goal-oriented hemodynamic therapy in critically ill patients. N. Engl. J. Med. 333: 1025-1032, 1995[Abstract/Free Full Text].

10.   Graham, T. E., and B. Saltin. Estimation of the mitochondrial redox state in human skeletal muscle during exercise. J. Appl. Physiol. 66: 561-566, 1989[Abstract/Free Full Text].

11.   Hayes, M. A., A. C. Timmins, E. H. S. Yau, M. Palazzo, C. J. Hinds, and D. Watson. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N. Engl. J. Med. 330: 1717-1722, 1994[Abstract/Free Full Text].

12.   Kainuma, M., Y. Fujiwara, N. Kimura, A. Shitalkoshi, K. Nakashima, and Y. Shimada. Monitoring hepatic venous hemoglobin oxygen saturation in patients undergoing liver surgery. Anesthesiology 74: 49-52, 1991[Medline].

13.   Koretsky, A. P., M. J. Brosnan, L. Chen, J. Chen, and T. Van Dyke. NMR detection of creatine kinase expressed in liver of transgenic mice: determination of free ADP levels. Proc. Natl. Acad. Sci. USA 87: 3112-3116, 1990[Abstract/Free Full Text].

14.   Lautt, W. W., J. Schafer, and D. J. Legare. Hepatic blood flow distribution: consideration of gravity, liver surface, and norepinephrine on regional heterogeneity. Can. J. Physiol. Pharmacol. 71: 128-135, 1992.

15.   Lehninger, A. L., H. C. Sudduth, and J. B. Wise. D-b-Hydroxybutyric dehydrogenase of mitochondria. J. Biol. Chem. 235: 2450-2455, 1960[Free Full Text].

16.   Mellanby, J., and D. H. Williamson. Acetoacetate. In: Methods of Enzymatic Analysis, edited by H. U. Bergmeyer. New York: Academic, 1974, p. 1840-1843.

17.   Metzger, H. P., and M. Schywalsky. Intraorgan differences in blood flow, oxygen supply and glycogen content in the multilobular liver of normal and hemorrhagic rats. Int. J. Microcirc. Clin. Exp. 11: 67-83, 1992[Medline].

18.   Ozawa, K. Liver Surgery Approached Through the Mitochondria. Tokyo: Karger, Medical Tribune, 1992.

19.   Rozenfeld, R. A., M. K. Dishart, T. I. Tønnessen, and R. Schlichtig. Methods for detecting local intestinal ischemic anaerobic metabolic acidosis by PCO2. J. Appl. Physiol. 81: 1834-1842, 1996[Abstract/Free Full Text].

20.   Samsel, R. W., and P. T. Schumacker. Determination of the critical O2 delivery from experimental data: sensitivity to error. J. Appl. Physiol. 64: 2074-2082, 1988[Abstract/Free Full Text].

21.   Schlichtig, R. The effectiveness of right heart catheterization in the initial care of critically ill patients (Letter). JAMA 277: 112, 1997.

22.   Schlichtig, R. O2 uptake, O2 delivery, and tissue wellness. In: Pathophysiologic Foundations of Critical Care, edited by M. R. Pinsky, and J. F. Dhainaut. Baltimore, MD: Williams & Wilkins, 1993, p. 127-129.

23.   Schlichtig, R., and S. A. Bowles. Distinguishing between aerobic and anaerobic appearance of PCO2 in intestine during low flow. J. Appl. Physiol. 76: 2443-2451, 1994[Abstract/Free Full Text].

24.   Schlichtig, R., H. A. Klions, D. J. Kramer, and E. M. Nemoto. Hepatic dysoxia commences during O2 supply dependence. J. Appl. Physiol. 72: 1499-1505, 1992[Abstract/Free Full Text].

25.   Seldinger, S. I. Catheter replacement of the needle in percutaneous arteriography. Acta Radiol. 39: 368-376, 1953[Medline].

26.   Schywalsky, M., and H. P. Metzger. Redistribution of local hepatic blood flow during acute bleeding and prolonged hemorrhagic hypotension studied using fluorochromed plasma proteins and surface PO2 measurements. Adv. Exp. Med. Biol. 277: 697-703, 1990[Medline].

27.   Sies, H. Oxygen gradients during hypoxic steady states in liver. Hoppe Seylers Z. Physiol. Chem. 358: 1021-1032, 1977[Medline].

28.   Stacpoole, P. W., E. M. Harman, S. H. Curry, T. G. Baumgartner, and R. I. Misbin. Treatment of lactic acidosis with dichloroacetate. N. Engl. J. Med. 309: 390-396, 1983[Abstract].

29.   Steenbergen, C., G. Deleeuw, C. Barlow, B. Chance, and V. R. Williamson. Heterogeneity of the hypoxic state in perfused rat heart. Circ. Res. 41: 606-615, 1977[Abstract/Free Full Text].

30.   Vallet, B., S. E. Curtis, B. Guery, J. Mangalaboyi, P. Menager, S. M. Cain, C. Chopin, and B. A. Dupuis. ATP-sensitive K+ channel blockade impairs O2 extraction during progressive ischemia in pig hindlimb. J. Appl. Physiol. 79: 2035-2042, 1995[Abstract/Free Full Text].

31.   Williamson, D. H., and J. Mellanby. D-(-)-3-Hydroxybutyrate. In: Methods of Enzymatic Analysis, edited by H. U. Bergmeyer. New York: Academic, 1974, p. 1836-1839.

32.   Wilson, D. F., M. Erecinska, C. Drown, and I. A. Silver. The oxygen dependence of cellular energy metabolism. Arch. Biochem. Biophys. 195: 485-493, 1979[Medline].


JAP 84(3):791-797
0161-7567/98 $5.00 Copyright © 1998 the American Physiological Society



This article has been cited by other articles:


Home page
Anesth. Analg.Home page
J. J. Tenhunen, A. Uusaro, V. Karja, N. Oksala, S. M. Jakob, and E. Ruokonen
Apparent Heterogeneity of Regional Blood Flow and Metabolic Changes Within Splanchnic Tissues During Experimental Endotoxin Shock
Anesth. Analg., August 1, 2003; 97(2): 555 - 563.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. LIAUDET, J. G. MABLEY, F. G. SORIANO, P. PACHER, A. MARTON, G. HASKO, and C. SZABO
Inosine Reduces Systemic Inflammation and Improves Survival in Septic Shock Induced by Cecal Ligation and Puncture
Am. J. Respir. Crit. Care Med., October 1, 2001; 164(7): 1213 - 1220.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
O. Raza and R. Schlichtig
Metabolic component of intestinal PCO2 during dysoxia
J Appl Physiol, December 1, 2000; 89(6): 2422 - 2429.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
T. Duke
Dysoxia and lactate
Arch. Dis. Child., October 1, 1999; 81(4): 343 - 350.
[Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dishart, M. K.
Right arrow Articles by Gayowski, T. J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dishart, M. K.
Right arrow Articles by Gayowski, T. J. P.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online